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Figure S1: Identification of CK pathway genes as stomatal lineage or SPCH targets, related to Figure 1. 
A) SPCH ChIP-seq profiles of the key stomatal regulators and set of CK metabolism and signaling associated 
genes (from data in Lau et al., 2014). ChIP-seq was performed on 4 day old Col-0 and pSPCH-SPCH2-4A-MY-
C;spch using antibodies against the MYC epitope. Peaks scores of higher than 3 are considered significant (FDR 
<10-6). Arrows indicate transcriptional start sites and orientation of genes.
B) Response of genes in (A) to 8-hr estradiol induction of pEST-SPCH-1-4A vs. control derived from RNA-seq on 
4 day old seedlings (from data in Lau et al., 2014). This timepoint was chosen because MUTE, a marker of GMC 
identity is not yet induced, and we wished to avoid changes in cell identity that might have secondary effects on 
gene expression. Y-axis values represents log2-transformed expression values.
C–E) Coexpression of SPCH and ARR16 in the epidermis of cotyledons in 3 day old seedlings. Arrows point to 
persistence of ARR16 in SLGCs (SLGCs are distinguished by relatively low SPCH compared to smaller neighbor 
cell) after an asymmetric division C) pSPCH-SPCH-YFP, D) pARR16-ARR16-CFP and E) merged. Cell outlines 
(magenta) marked with pML1pro-mCherry-RCI2A; scale bars, 10 μm.
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Figure S2: Transgenic manipulation of CK levels changes cell division competence and SI but does not 
alter cell polarity, related to Figure 2.
Quantification of epidermal cell numbers and SI in 10 day old cotyledons, from same genotypes analyzed at day 
4 in Figure 2. 
A–B) Col-0, pML1-CKX3, and pML1-IPT7 (n=8/genotype).
C–D) Col-0, pBASL-CKX3, and pBASL-IPT7 (n=8/genotype). Cell numbers in 10 day old pBASL-CKI1 lines 
could not be accurately quantified because excessive divisions lead to a distorted epidermal surface.
E–F) Col-0, pMUTE-CKX3, pMUTE-IPT7, and pMUTE-CKI1 (n=8 genotype).
G) Polarity marker BRXL2-BRXL2-YFP expression in 7 day old Col-0 and (H) pBASL-CKI1 true leaves. Scale 
bars, 10 μm. ***p<0.001 by Dunnet’s test.
Figure S3: Members of CK signaling pathway modulate cell division potential in SLGCs, related to Figure 3.
A–C) Quantification of cotyledon epidermis phenotypes in Col-0 and CK biosynthesis mutants ipt1357 and ipt1345678 (n>10/genotype), (A) cell number 
at 4 days (B) cell number at 10 days and (C) SI at 10 days.
D) Fraction of SLGCs going through spacing divisions in 4 day old Col-0 (n=306), ipt1357 (n=323), and ipt1345678 (n=379) on the adaxial side of the 
cotyledons. Co-0 quantification from Figure 3D was used as a control. At least 13 cotyledons per genotype were scored.
E-G) Quantification of cotyledon epidermis phenotypes in Col-0, and three independent lines of arr16 and arr16 arr17 (n=11/genotype), (E) cell number 
at 4 days (F) cell number at 10 days and (G) SI at 10 days.
H) Fraction of SLGCs going through spacing divisions in 4 day old Col-0 (n=574), arr16 #1 (n=413), arr16 #2 (n=816), arr16 #3 (n=591), arr16 arr17 #1 
(n=511), arr16 arr17 #2 (n=715), and arr16 arr17 #3 (n=654) on the adaxial side of the cotyledons. At least 12 cotyledons per genotype were scored.
I) Brightfield image of pARR17-GUS (blue), expressed sporadically in the leaf epidermis and in the inner part of the developing leaf in 7 day old seedling.
J) Expression of translational pARR17-gARR17-YFP reporter is observed sporadically in the mature GCs and (j) SLGCs in true leaves of 10 day old 
seedling. J and j are from different seedlings.
K) Confocal image of 4 day old cotyledon overexpressing (OE) ARR16-YFP with the TMM promoter to show early stomatal lineage focused expression. 
Arrowhead, early stomatal lineage cell with high ARR16 expression levels; arrow, mature stomata without ARR16 expression. Cell outlines were marked 
with PI. Scale bar, 10 μm. 
L) Quantification of cell number in Col-0 and two independent ARR16-OE lines (n=11/genotype) at 10 day old cotyledon epidermis.
M) Quantification of cotyledon area in Col-0, ahk2/+ ahk3 cre1, arr16 arr17 #1 and two independent ARR16-OE lines (n=9-12/genotype) at day 21. 
*p<0.05, **p<0.01, ***p<0.001 by Dunnett’s test (B-C, E-G, M) or by Dunn’s test (A, L).
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Figure S4: Evidence that CLE9 and CLE10 are SPCH targets and analysis of additional CRISPR alleles, 
related to Figure 4.
A) SPCH ChIP-seq profiles of the genes encoding CLE peptides (from data in Lau et al., 2014). ChIP-seq was 
performed on 4 day old Col-0 and pSPCH-SPCH2-4A-MYC;spch using antibodies against the MYC epitope. 
Peaks scores of higher than 3 are considered significant (FDR <10-6). Arrows indicate transcriptional start sites 
and orientation of genes.
B) Response of genes in (B) to 8-hr estradiol induction of pEST-SPCH-1-4A vs. control derived from RNA-seq on 
4 day old seedlings (from data in Lau et al., 2014). Y-axis values represents log2-transformed expression values.
C-E) Quantification of cotyledon epidermis phenotypes in Col-0, and two independent cle9 and four independent 
cle9 cle10 lines (n=10/genotype), (C) cell number at 4 days (D) cell number at 10 days and (E) SI at 10 days.
F) Fraction of SLGCs going through spacing divisions in 4 day old Col-0 (n=836), cle9 #1 (n=474), cle9 #2 
(n=433), cle9 cle10 #1 (n=709), cle9 cle10 #2 (n=641), cle9 cle10 #3 (n=875), and cle9 cle10 #4 (n=298) on the 
adaxial side of the cotyledons. At least 7 cotyledons per genotype were scored.
G) Quantification of fluorescence intensity of TCSn1-2xYPET-N7 in SLGCs at abaxial side of cotyledons in 4d 
outcrossed heterozygous cle9 cle10 -/+ (n=7) and backcrossed homozygous cle9 cle10 (n=10) FI seedlings (a.u., 
arbitrary unit).
H) Quantification of cotyledon area in Col-0 (n=10) and cle9 cle10 #1 (n=12) at day 21. *p<0.05, **p<0.01 by 
Dunnett’s test (D-E), Dunn’s test (C), or by Mann-Whitney test (G-H).
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Figure S5: SPCH and CK form an expression feedback loop, related to Figure 5.
A-B) Extended timelapse of pSPCH-SPCH-CFP;  pMUTE-MUTE-YFP; pML1-mcherry-RC12A in Col-0 (A) and 
pBASL-CKI1 (B) 3 day old seedlings. Single asterisk, SPCH expressing cell divides; arrow, reduced SPCH expres-
sion in one of the daughter cells; arrowhead, increased SPCH levels in SLGC; two asterisks, divided SLGC. Time-
point in the movie is indicated below each image. A subset of the images presented in Figure S5-B are presented 
in Figure 5A-B and same labeling has been used. This excerpting means that markings are shown sometimes in 
later timepoints compared to Figure S5A-B. In Figure S5A two arrows indicating reduced SPCH expression are 
shown at 5h timepoint whereas in Figure 5A they are shown at 6h timepoint. In Figure S5B two set of double aster-
isks indicating SLGC division are shown at 9h and 16h timepoints whereas in Figure 5 they are shown at 11h and 
25h timepoints. 
C–D) TCSn-GFP-ER intensity is increased by 5 hour 10 μM tZ treatment at adaxial side of cotyledons in 3d old 
seedlings.
E) qRT-PCR analysis of MUTE, SPCH, and ARR16 expression as a response to 30 minute 10μM tZ treatment. 
Expression values are normalized to the control gene ACTIN2 and are relative to the expression in the mock treated 
seedlings. 
F) Quantification of total cell number per 0.04 mm2 in 4 day old mute and heterozygous or WT siblings transformed 
with pBASL-CKI1 or a control transgene with same antibiotic resistance (n=10/genotype). Analysis was done on 4d 
old etiolated T1 seedlings.
G) TCSn-GFP-ER is expressed in the GCs and subset of SLGCs in the true leaves of 7 day old wild-type, however, 
in spch (H) TCSn1-GFP-ER signal is severely reduced. 
I) TCSn-GFP-ER expression restricted to GCs and is absent from meristemoids and SLGCs in 7 day old true leaves 
of pSPCH-SPCH1-4A-CFP. Scale bars in A-B, 10 μm; scale bars in C-D, G-I 50 μm. ***p<0.001 by Student t-test.
	
Table S1. CRISPR induced mutations used in this study, related to Figure 3, S3, 
Figure 4, and S4. 
 
Locus Mutation Nucleotide change Effects on protein 
ARR16 arr16-1 Insertion of T at nt position 12, leads to premature 
stop codon 
Out of frame after 4 
aa, 17 aa protein 
ARR16 arr16-2 Deletion of  5 nt (TTCAG) at nt position 9, leads to 
premature stop codon 
out of frame after 1 
aa, 15 aa protein 
ARR16 arr16-3 Insertion of A at nt position 12, leads to premature 
stop codon 
Out of frame after 4 
aa, 17 aa protein 
ARR17 arr17 Insertion of T at nt position 99, leads to premature 
stop codon 
Out of frame after 32 
aa, 35 aa protein 
CLE9 cle9-1 Insertion of C at nt position 74, leads to premature 
stop codon 
Out of frame after 24 
aa, 52 aa protein 
CLE9 cle9-2 Insertion of A at nt position 74, leads to premature 
stop codon 
Out of frame after 24 
aa, 52 aa protein 
CLE10 cle10-1 Insertion of A at nt positions 15 and 65 Out of frame after 5 
aa, 118 aa protein 
CLE10 cle10-2 Large deletion at nt position 50, leads to 
premature stop codon 
Out of frame after 5 
aa, 70 aa protein 
CLE10 cle10-3 Large deletion at nt position 60 Out of frame after 5 
aa, 107 aa protein 
CLE10 cle10-4 Large deletion at nt position 15, leads to 
premature stop codon 
Out of frame after 5 
aa, 21 aa protein 
 
 
Effects of CRISPR/Cas9 induced editing at DNA and protein level in mutant lines created for this 
study. nt, nucleotide; aa, amino acid. 
 
Table S2. CRISPR induced mutant lines and their edited nucleotide sequencies, related 
to  Figure 3, S3, Figure 4, and S4.  
 
List of all the mutant lines created by CRISPR/Cas9-induced editing for this study. The last column (nucleotide 
sequence) shows the WT genomic sequences and the altered target sequences in each mutant. 
 
 
Line Locus Mutation Nucleotide sequence 
Col-0 ARR16  Wild-type ATGAACAGTTCAGGAGGTTCTTGTTCGTCTTTAATGGATGTGGTGGCTTAT
GATCATCATCTTCATCATGGTCATGATGAAGAGCTTCATGTTTTAGCTGTAG
ATGATAATCTTATTGACCGTAAACTCGTTGAGAGGTTGCTCAAGATCTCTT
GTTGCAAAGgttcaatcattttacctttcatgttttataatcaatcattactttatgcaatctttgtctctaaaatgtg
aatttttgcagTGACAACAGCAGAGAATGCGCTTAGAGCATTGGAGTATTTGGGT
TTGGGAGATCAAAATCAGCATATTGATGCATTGACCTGTAACgtaagcaaaaaa
aaaacatataaaatcttcaagatctatggatttttttccttaggacatatttgatattaggtttatatatgtgtggattttc
tagGTTATGAAGGTGAGTCTAATCATCACCGATTACTGTATGCCTGGAATGA
CAGGTTTTGAGCTACTCAAGAAAGTGAAGgtaattatataacagcttcttggaaccaatatc
cagagatttatattaacctaaaaatcttctgtgtgtttctttagCAGGAGTCATCAAATCTGAGAGA
GGTTCCTGTTGTGATAATGTCTTCAGAGAATATTCCTACTCGCATAAACAAg
taagaacaaattgagatcagattaagaacttgtttctgtgtttcttatagtgtaagtaattagtaaag 
arr16 #1 ARR16 arr16-1 ATGAACAGTTCTAGGAGGTTC 
arr16 #2 ARR16 arr16-2 ATGAACAG - - - - - GAGGTTC 
arr16 #3 ARR16 arr16-3 ATGAACAGTTCAAGGAGGTTC 
arr16 17#1 ARR16 arr16-1 ATGAACAGTTCTAGGAGGTTC 
arr16 17#2 ARR16 arr16-1 ATGAACAGTTCTAGGAGGTTC 
arr16 17 #3 ARR16 arr16-1 
arr16-3 
ATGAACAGTTCAAGGAGGTTC 
ATGAACAGTTCTAGGAGGTTC 
Col-0 ARR17 Wild-type GTAAACT 
arr17 ARR17 arr17 GTAATACT 
arr16 17 #1 ARR17 arr17 GTAATACT 
arr16 17 #2 ARR17 arr17 GTAATACT 
arr16 17 #3 ARR17 arr17 GTAATACT 
Col-0 CLE9 Wild-type CTCCACC 
cle9 #1 CLE9 cle9-1 CTCCACCC 
cle9 #2 CLE9 cle9-2 CTCCAACC 
cle9 10 #1 CLE9 cle9-2 CTCCAACC 
cle9 10 #2 CLE9 cle9-2 CTCCAACC 
cle9 10 #3 CLE9 cle9-2 CTCCAACC 
cle9 10 #4 CLE9 cle9-2 CTCCAACC 
Col-0 CLE10 Wild-type ATGAAGACTAACCGGAACCGTCCGATCAACATCCTCATCGTCTTCTTCCTT
CTTACGACCGCAAGAGCAGCAACAAGAAACTGGACCAACCGAACTCACCG
AACCGTCCCTAAGGTT 
cle9 10 #1 CLE10 cle10-1 ATGAAGACTAACCGGAAACCGTCCGATCAACATCCTCATCGTCTTCTTCCT
TCTTACGACCGCAAAGAGCAG 
cle9 10 #2 CLE10 cle10-2 ATGAAGACTAACCGGAACCGTCCGATCAACATCCTCATCGTCTTCTTCCT - 
- - - - 
cle9 10 #3 CLE10 cle10-3 ATGAAGACTAACCGGAACCGTCCGATCAACATCCTCATCGTCTTCTTCCTT
CTTACGACC - - - - - 
cle9 10 #4 CLE10 cle10-4 ATGAAGACTAACCGG - - - - - 	
Dashed line, deletion; bold, insertion; underlined, ATG. 
Table S3. Type-B ARR binding motifs are frequent around the SPCH locus, related 
to Figure 5. 
 
Analysis of the frequency of type-B ARR binding core motifs 5´-(A/G)GAT(C/T)-3´ in SPCH and MUTE 
loci. Previous studies defined that CK regulated type-A ARRs contain the type-B ARR binding motif on 
average once in every 86 base pairs (bp) whereas non-CK regulated genes contain it less frequently 
(once in 119 bp) (Zürcher et al., 2013).  
 
 
  sequence 
length 
total 
hits  
density: hits 
per N bp 
distance 
(>30) 
distance 
(6-30) 
(6-30), 
tandem 
(6-30), 
inverted 
SPCH 
locus with 
2.5 Kb 
upstream 
region 
4912 52 94.46153846 38 7 3 3 
MUTE 
locus 
with 1.8 Kb 
upstream 
region 
  
3454 27 127.92592 19 8 2 6 
 
Table S4. Description of experiments defining fraction of SLGC divisions, 
related to Figure 3, S3, Figure 4, and S4. 
 
Detailed description of experiments indicating the total counts of divided and undivided SLGCs and the 
ratio of these counts and the number of cotyledons scored for each genotype and experiment. 
 
* The same Col-0 samples (grow together with ckx and ipt mutants) were used as controls in 3D and S3D 
 
 Genotype 
Fraction of cells undergoing 
spacing divisions % 
Cotyledons 
scored 
3D* 
 
 
Col-0 189/306 61.8 13 
ckx346 442/619 71.4 19 
3H 
 
 
 
 
 
Col-0 128/243 52.7 7 
ahk3 cre1 91/203 44.8 7 
ahk2/+ ahk3 cre1 115/305 37.7 8 
ahk2 ahk3 cre1 28/266 10.5 7 
3L 
 
 
 
 
 
Col-0 145/289 50.2 7 
arr16 arr17 #1 200/303 66.0 7 
arr16 arr17 #2 187/287 65.2 7 
arr16 arr17 #3 187/292 64.0 7 
3N 
 
 
Col-0 264/465 56.8 18 
ARR16-OE 60/275 21.8 16 
S3D* 
 
 
 
Col-0 189/306 61.8 13 
ipt1357 149/323 46.1 17 
ipt1345678 132/379 34.8 15 
S3H 
 
 
 
 
 
 
 
 
 
 
Col-0 302/574 52.6 14 
arr16 #1 243/413 58.8 12 
arr16 #2 447/816 54.8 17 
arr16 #3 322/591 54.5 14 
arr16 arr17 #1 330/511 64.6 12 
arr16 arr17 #2 474/715 66.3 14 
arr16 arr17 #3 433/654 66.2 15 
4H 
 
 
 
Col-0 305/541 56.4 32 
cle9 cle10 606/819 74.0 32 
cle9 cle10; ARR16-OE 136/345 39.4 19 
4K 
 
 
 
 
 
Col-0 255/424 60.1 12 
arr16 arr17 298/428 69.6 13 
cle9 cle10 519/709 73.2 15 
arr16 arr17 cle9 cle10 421/581 72.5 15 
S4F 
 
 
 
 
 
 
 
 
 
 
Col-0 496/836 59.3 22 
cle9 #1 297/474 62.7 13 
cle9 #2 276/433 63.7 15 
cle9 cle10 #1 519/709 73.2 15 
cle9 cle10 #2 447/641 69.7 14 
cle9 cle10 #3 621/875 71.0 14 
cle9 cle10 #4 218/298 73.2 7 
Table S5. List of primers used in this study, related to STAR methods. 
 
Genotyping primers 
ckx4-1 
ckx4-1 LP GGTCACGGTGATTCGTAGATG  
ckx4-1 RP AAACTCACACGCCATAACCAG 
ckx3-2 
ckx3-2 LP ATACATGTGTCTGCATGCGTG 
ckx3-2 RP TAGACCAACCACCAATTTTGC 
ckx6-2 
ckx6-2 LP TCTACAGTGTGGATTCCCCTG 
ckx6-2 RP CCTTTCGATCGGAGTTTTACC 
ckx5-1 
ckx5-1 LP CGAGCTTCAAAGTGTTTACGG 
ckx5-1 RP TCCCCACAAGTGTAACTTTGC 
arr16 
ARR16 UTR F TACCATCACCAGAGATTCAC  
gARR16 R GCTTCTGCAGTTCATGAGATGA 
arr17 
ARR17 pro F GTCTGACTCATTTATTCTCCTCC 
gARR17 R  GCTTCTGCAATTTAAAAGATGG 
cle9 
CLE 9 seq F CAAGCGTGGAAATAGCTTAGTTAC 
CLE 9 seq R  CGGGTTGGTATTTATGTCAATGAAAAC  
cle10 
CLE10 seq F GATGCAGTAATAACAAGGAAGTGAAG 
CLE10 seq R GGAAATTGTAACTTTCCGATAAAG 
 
qRT-PCR primers 
ACTIN 
ACTIN qPCR F CAAGGCCGAGTATGATGAGG 
ACTIN qPCR R GAAACGCAGACGTAAGTAAAAAC 
ARR16 
ARR16 qPCR F TGCAAAGTGACAACAGCAGA 
ARR16 qPCR R CCAGGCATACAGTAATCGGT 
SPCH 
SPCH qPCR F GCTGCTCTTGAAGATTTGGCTC 
SPCH qPCR R GCACTCAATTCCAATCTTGATGGTG 
MUTE 
MUTE qPCR F CAAAAGGGGAGATCAAGCTTCG 
MUTE qPCR R GGTCTTTCGACGTTTCTTGGAC 
 
Primers used for DNA manipulation 
CKX4 pro 
CKX4 pro F CCCCACGCGTTGTTGCTAAGCTCTTCTTCTTCTTCTTCGA 
CKX4 pro R CCCCACGCGTTGTTGCTAAGCTCTTCTTCTTCTTCTTCGA 
ARR16 pro 
ARR16 pro F AATATGAATTCTAAACTCAGTTGATACTTC 
ARR16 pro R AATATGAATTCGATCTCCTTTGTTCCTTAAA 
ARR17 pro 
ARR17 pro F AATATGAATTCGATCTCCTTTGTTCCTTAAA 
ARR17 pro R CTCCTACGATTACAGAGAGAT 
ARR18 pro 
ARR18 pro F AATATGAATTCGATCTCCTTTGTTCCTTAAA 
ARR18 pro R TCCTACAGGAAACTTGTCATGC 
ARR22 pro 
ARR22 pro F GTGATTTCTGTCAACTAAATG 
ARR22 pro R CTTCGATTTCTTTTCTCTCA 
CLE9 pro 
CLE9 pro F ATCAGAACCTGAGAACTATAG 
CLE9 pro R TGTTTTGGTTTCCAAGAGAG 
CLE10 pro 
CLE10 pro F GATTCAACAAAACCGGTACAACG 
CLE10 pro R CGTTGTGGAGAGAGAGAGAGAG 
TCSn1 pro 
TCSn1 pro F CCCTCGAGCCCGGGTCCTCTCCAAATGAAATGAACTTCCTTATATA 
TCSn1 pro R CCCACGCGTAAGCTTGACTAGTCAAAGATCTTTAA 
pENTR CKI1 
pENTR CKI1 F CACCATGATGGTGAAAGTTACAAAGC 
pENTR CKI1 R CTAGTGACGTTTGCTTTCGA 
pENTR CKX3 
pENTR CKX3 F CACCAAAAAAATGGCGAGTTATAATCTTCGTT 
pENTR CKX3 R CTAACTCGAGTTTATTTTTTGAAAT 
pENTR IPT7 
pENTR IPT7 F CACCGCCACCATGAAGTTCTCAATCTCATCACTGAAGC 
pENTR IPT7 R TCATATCATATTGTGGGCTCTACTT 
pENTR ARR16 
pENTR ARR16 F CACCATGAACAGTTCAGGAGGTT 
pENTR ARR16 R GCTTCTGCAGTTCATGAGATGA 
pENTR ARR17 
pENTR ARR17 F CACCATGAATAAGGGCTGTGGAAG 
pENTR ARR17 R GCTTCTGCAATTTAAAAGATGG 
pENTR ARR18 
pENTR ARR18 F CACCATGAGGGTTCTTGCTGTGGA 
pENTR ARR18 R AGGTGGAGGAAATGAATCAAAGCC 
pENTR SPCH 
pENTR SPCH F CACCATGCAGGAGATAATACCGG 
pENTR SPCH R GCAGAATGTTTGCTGAATTTGTTGAGCC 
 
Table S6. Description of all transgenic lines created and analyzed, related to STAR 
methods.  
 
Transgenic lines created for this 
study 
    Nro of independent lines 
analyzed 
pCKX4-2xΩYpet-N7  9 
pARR16-gARR16-CFP 9 
pARR22-YFP  8 
pARR18-gARR18-YFP 9 
pARR17-gARR17-YFP 5 
pML1-CKX3 13 
pML1-IPT7 9 
pBASL-CKX3 9 
pBASL-IPT7 14 
pBASL-CKI1 25 
pMUTE-CKX3 8 
pMUTE-IPT7 14 
pMUTE-CKI1 12 
pTMM-gARR16-YFP 13 
pARR17-GUS 10 
pCLE9-YFP 12 
pCLE10-YFP 8 
pTCSn1-2xΩYpet-N7 in cle9 cle10 #1  11 
pTMM-ARR16-YFP in cle9 cle10 #1 10 
pBASL-CKI1 in mute-/+ 15 
pSPCH-SPCH-YFP in arr16 arr17 #1 5 
 
